Literature DB >> 15197588

Elicitation of reactive oxygen species in Chlamydia pneumoniae-stimulated macrophages: a Ca2+-dependent process involving simultaneous activation of NADPH oxidase and cytochrome oxidase genes.

Anthony A Azenabor1, Shoua Yang, Godwin Job, Olanrewaju O Adedokun.   

Abstract

Chlamydia pneumoniae, a respiratory pathogen implicated in the development and progress of atherosclerosis, is known to infect and survive in macrophages, despite macrophage producing reactive oxygen species (ROS). To gain insight into ROS generation in macrophages infected with C. pneumoniae and to explore factors accounting for their final levels and effect, we investigated the role of NADPH oxidase and cytochrome oxidase pathways in the production and modulation of ROS. We also determined the operational role of Ca2+ signaling in the process. Macrophages stimulated with C. pneumoniae exhibit early release of ROS via up-regulation of NADPH oxidase and cytochrome c oxidase activities. Increasing the dose of C. pneumoniae led to an increase in the expression of these enzymes gene production, which was accompanied by a significant up-regulation of their gene products, implying a probable activation of transcriptional and translational processes, respectively. The change in levels of free Ca2+, influx across plasma membrane and efflux from intracellular store into cytosol all exhibited a significant regulatory role on the ROS generation pathways in macrophages. The observed events were shown to be dependent on binding of C. pneumoniae to CD14 receptors of macrophages. The data reported here imply that macrophages infected with C. pneumoniae produce ROS through membrane-associated NADPH oxidase with oxidative phosphorylation levels depending on Ca2+ influx signals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15197588     DOI: 10.1007/s00430-004-0223-4

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  45 in total

Review 1.  Cells depleted of mitochondrial DNA (rho0) yield insight into physiological mechanisms.

Authors:  N S Chandel; P T Schumacker
Journal:  FEBS Lett       Date:  1999-07-09       Impact factor: 4.124

2.  Infection and nitric oxide.

Authors:  John B Hibbs
Journal:  J Infect Dis       Date:  2002-02-15       Impact factor: 5.226

3.  Effect of exhaustive exercise on membrane estradiol concentration, intracellular calcium, and oxidative damage in mouse thymic lymphocytes.

Authors:  A A Azenabor; L Hoffman-Goetz
Journal:  Free Radic Biol Med       Date:  2000-01-01       Impact factor: 7.376

4.  Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response.

Authors:  Robert A Mitchell; Hong Liao; Jason Chesney; Gunter Fingerle-Rowson; John Baugh; John David; Richard Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

5.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

6.  The potent adjuvant activity of archaeosomes correlates to the recruitment and activation of macrophages and dendritic cells in vivo.

Authors:  L Krishnan; S Sad; G B Patel; G D Sprott
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

7.  Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group.

Authors:  J A Ramirez
Journal:  Ann Intern Med       Date:  1996-12-15       Impact factor: 25.391

8.  Induction of lipoprotein lipase gene expression in Chlamydia pneumoniae-infected macrophages is dependent on Ca2+ signaling events.

Authors:  Anthony A Azenabor; Godwin Job; Shoua Yang
Journal:  Biol Chem       Date:  2004-01       Impact factor: 3.915

Review 9.  Chlamydia pneumoniae, strain TWAR and atherosclerosis.

Authors:  J T Grayston; C C Kuo; L A Campbell; E P Benditt
Journal:  Eur Heart J       Date:  1993-12       Impact factor: 29.983

10.  Human keratinocytes express functional CD14 and toll-like receptor 4.

Authors:  Peter I Song; Young-Min Park; Tonya Abraham; Brad Harten; Adam Zivony; Natalia Neparidze; Cheryl A Armstrong; John C Ansel
Journal:  J Invest Dermatol       Date:  2002-08       Impact factor: 8.551

View more
  9 in total

1.  Chlamydia pneumoniae infected macrophages exhibit enhanced plasma membrane fluidity and show increased adherence to endothelial cells.

Authors:  Anthony A Azenabor; Godwin Job; Olanrewaju O Adedokun
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

2.  Dibenzocyclooctadiene lignans from Schisandra spp. selectively inhibit the growth of the intracellular bacteria Chlamydia pneumoniae and Chlamydia trachomatis.

Authors:  Elina Hakala; Leena Hanski; Hanna Uvell; Teijo Yrjönen; Heikki Vuorela; Mikael Elofsson; Pia Maarit Vuorela
Journal:  J Antibiot (Tokyo)       Date:  2015-05-06       Impact factor: 2.649

Review 3.  Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets.

Authors:  Grant R Drummond; Stavros Selemidis; Kathy K Griendling; Christopher G Sobey
Journal:  Nat Rev Drug Discov       Date:  2011-06       Impact factor: 84.694

4.  Enhancement of reactive oxygen species production and chlamydial infection by the mitochondrial Nod-like family member NLRX1.

Authors:  Ali A Abdul-Sater; Najwane Saïd-Sadier; Verissa M Lam; Bhavni Singh; Matthew A Pettengill; Fraser Soares; Ivan Tattoli; Simone Lipinski; Stephen E Girardin; Philip Rosenstiel; David M Ojcius
Journal:  J Biol Chem       Date:  2010-10-19       Impact factor: 5.157

Review 5.  Chlamydia pneumoniae and oxidative stress in cardiovascular disease: state of the art and prevention strategies.

Authors:  Marisa Di Pietro; Simone Filardo; Fiorenzo De Santis; Paola Mastromarino; Rosa Sessa
Journal:  Int J Mol Sci       Date:  2014-12-30       Impact factor: 5.923

6.  Neuroprotective effects of some epigenetic modifying drugs' on Chlamydia pneumoniae-induced neuroinflammation: A novel model.

Authors:  Elif Kaya-Tilki; Miriş Dikmen
Journal:  PLoS One       Date:  2021-11-30       Impact factor: 3.240

Review 7.  Chlamydia pneumoniae infection in atherosclerotic lesion development through oxidative stress: a brief overview.

Authors:  Marisa Di Pietro; Simone Filardo; Fiorenzo De Santis; Rosa Sessa
Journal:  Int J Mol Sci       Date:  2013-07-19       Impact factor: 5.923

8.  Infection of human monocytes by Chlamydia pneumoniae and Chlamydia trachomatis: an in vitro comparative study.

Authors:  Antonella Marangoni; Christian Bergamini; Romana Fato; Claudia Cavallini; Manuela Donati; Paola Nardini; Claudio Foschi; Roberto Cevenini
Journal:  BMC Res Notes       Date:  2014-04-11

Review 9.  Infectious Agents in Atherosclerotic Cardiovascular Diseases through Oxidative Stress.

Authors:  Marisa Di Pietro; Simone Filardo; Francesca Falasca; Ombretta Turriziani; Rosa Sessa
Journal:  Int J Mol Sci       Date:  2017-11-18       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.